Want to join the conversation?
Andrew Kaplowitz of Citigroup asks about pricing and raw material. CFO Nick Gangestad answers that margin expansion in 2Q16 was helped by lower year-on-year commodity prices and pricing growth. For 2016, $MMM expects the combination of the price/raw materials to benefit margins by approx. 100 basis points.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.